B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Zimlovisertib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Zimlovisertib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

whi
2 shared targets
alectinib
2 shared targets
mk
2 shared targets
pf
2 shared targets
canertinib
3 shared targets
ponatinib
2 shared targets
quizartinib
2 shared targets
plx
2 shared targets
bi
2 shared targets
gefitinib
2 shared targets
Loading evidence profile...

This evidence profile for Zimlovisertib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.